66.18
price down icon1.55%   -1.04
after-market アフターアワーズ: 66.25 0.07 +0.11%
loading
前日終値:
$67.22
開ける:
$66.53
24時間の取引高:
3.00M
Relative Volume:
0.99
時価総額:
$12.53B
収益:
$2.83B
当期純損益:
$-1.02B
株価収益率:
-12.01
EPS:
-5.51
ネットキャッシュフロー:
$194.14M
1週間 パフォーマンス:
+2.30%
1か月 パフォーマンス:
+14.60%
6か月 パフォーマンス:
+24.21%
1年 パフォーマンス:
+24.33%
1日の値動き範囲:
Value
$64.92
$67.27
1週間の範囲:
Value
$64.02
$72.81
52週間の値動き範囲:
Value
$38.81
$72.81

Exact Sciences Corp Stock (EXAS) Company Profile

Name
名前
Exact Sciences Corp
Name
セクター
Healthcare (1134)
Name
電話
608-284-5700
Name
住所
5505 ENDEAVOR LANE, MADISON, WI
Name
職員
7,000
Name
Twitter
@exactsciences
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
EXAS's Discussions on Twitter

EXAS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
66.18 12.74B 2.83B -1.02B 194.14M -5.51
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
572.41 212.64B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
209.94 148.81B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
708.45 56.99B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
146.74 41.81B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
210.46 35.91B 15.90B 1.28B 2.21B 7.2842

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-10 開始されました Mizuho Outperform
2025-03-13 開始されました RBC Capital Mkts Sector Perform
2025-01-23 開始されました Barclays Overweight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Buy
2024-01-02 アップグレード The Benchmark Company Hold → Buy
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-10 アップグレード Piper Sandler Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-08-02 ダウングレード The Benchmark Company Buy → Hold
2023-05-10 アップグレード Craig Hallum Hold → Buy
2023-05-05 開始されました UBS Neutral
2023-03-09 アップグレード Citigroup Neutral → Buy
2023-02-10 ダウングレード Credit Suisse Outperform → Neutral
2023-01-18 ダウングレード Raymond James Outperform → Mkt Perform
2022-10-19 ダウングレード Craig Hallum Buy → Hold
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Neutral
2021-11-03 ダウングレード Raymond James Strong Buy → Outperform
2021-07-29 繰り返されました BTIG Research Buy
2021-07-29 繰り返されました Canaccord Genuity Buy
2021-07-29 繰り返されました Oppenheimer Outperform
2021-07-29 繰り返されました Stifel Buy
2021-06-15 開始されました Raymond James Strong Buy
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Equal Weight
2021-01-28 開始されました Truist Buy
2020-10-29 ダウングレード UBS Buy → Neutral
2020-10-28 ダウングレード Citigroup Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-04-02 開始されました Evercore ISI Outperform
2020-01-10 再開されました BTIG Research Buy
2020-01-07 開始されました Citigroup Buy
2019-12-13 開始されました Dougherty & Company Buy
2019-11-15 開始されました Stifel Buy
2019-10-17 繰り返されました BofA/Merrill Buy
2019-10-01 再開されました Craig Hallum Buy
2019-09-26 開始されました Oppenheimer Outperform
2019-02-26 アップグレード Goldman Neutral → Buy
2018-10-09 開始されました UBS Buy
2018-09-05 再開されました The Benchmark Company Hold
2018-08-13 繰り返されました Canaccord Genuity Buy
2018-04-03 アップグレード BTIG Research Neutral → Buy
2018-01-29 開始されました Goldman Neutral
2018-01-08 繰り返されました The Benchmark Company Buy
2017-11-13 ダウングレード Robert W. Baird Outperform → Neutral
2017-11-01 ダウングレード BTIG Research Buy → Neutral
すべてを表示

Exact Sciences Corp (EXAS) 最新ニュース

pulisher
10:59 AM

Exact Sciences announces results from ALTUS study - TipRanks

10:59 AM
pulisher
10:20 AM

Exact Sciences (EXAS) Is Up 6.3% After Oncoguard Liver Test Outperforms Ultrasound in ALTUS Study - Yahoo Finance

10:20 AM
pulisher
09:49 AM

Exact Sciences' Blood Test Detects Liver Cancer Far Earlier Than Standard Ultrasound - Nasdaq

09:49 AM
pulisher
08:46 AM

EXAS Unveils Promising Results from ALTUS Study with Oncoguard L - GuruFocus

08:46 AM
pulisher
08:25 AM

Exact Sciences’ liver cancer blood test shows superior early detection - Investing.com

08:25 AM
pulisher
08:02 AM

Exact Sciences blood test shows improved liver cancer detection - StreetInsider

08:02 AM
pulisher
08:00 AM

Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test - Business Wire

08:00 AM
pulisher
Nov 06, 2025

Herriott James, Exact Sciences Corp SVP, sells $105k in stock - Investing.com Canada

Nov 06, 2025
pulisher
Nov 06, 2025

Baranick, Exact Sciences EVP, sells $200k in EXAS stock - Investing.com

Nov 06, 2025
pulisher
Nov 06, 2025

Exact Sciences (EXAS) Gets a Hold from UBS - The Globe and Mail

Nov 06, 2025
pulisher
Nov 06, 2025

Why Exact Sciences Corporation stock remains on buy listsWeekly Trend Recap & Weekly Consistent Profit Watchlists - fcp.pa.gov.br

Nov 06, 2025
pulisher
Nov 06, 2025

How Exact Sciences Corporation stock performs in weak economy2025 Bull vs Bear & Daily Volume Surge Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Why Exact Sciences Corporation stock could see breakout soonJuly 2025 Sector Moves & AI Driven Price Forecasts - fcp.pa.gov.br

Nov 06, 2025
pulisher
Nov 06, 2025

Can Exact Sciences Corporation (EXK) stock stage a strong rebound this quarter - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Exact Sciences Corporation stock chart pattern explainedTrade Performance Summary & AI Optimized Trade Strategies - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Leading vs lagging indicators on Exact Sciences Corporation performance2025 Analyst Calls & Risk Managed Investment Signals - newser.com

Nov 06, 2025
pulisher
Nov 05, 2025

EXAS Stock Quote Price and Forecast - CNN

Nov 05, 2025
pulisher
Nov 05, 2025

Key facts: Exact Sciences raises 2025 revenue forecast to $3.23B; Wells Fargo boosts price target to $85 - TradingView

Nov 05, 2025
pulisher
Nov 05, 2025

Exact Sciences (NASDAQ:EXAS) Trading 8.1% Higher After Better-Than-Expected Earnings - MarketBeat

Nov 05, 2025
pulisher
Nov 05, 2025

EXAS: Wells Fargo Raises Price Target to $85.00, Maintains Overw - GuruFocus

Nov 05, 2025
pulisher
Nov 05, 2025

Is Exact Sciences Corporation stock a buy for dividend growthJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Exact Sciences Corporation (NASDAQ:EXAS) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 05, 2025
pulisher
Nov 05, 2025

Exact Sciences to Participate in November 2025 Investor Conference - BioSpace

Nov 05, 2025
pulisher
Nov 05, 2025

Exact Sciences Corp Faces Regulatory Risks Amid Potential Government Disruptions - TipRanks

Nov 05, 2025
pulisher
Nov 04, 2025

Why Exact Sciences Stock Blasted Higher on Tuesday - The Motley Fool

Nov 04, 2025
pulisher
Nov 04, 2025

Why Exact Sciences Stock Blasted Higher on Tuesday - Nasdaq

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences Corp Reports Strong Q3 Earnings - TipRanks

Nov 04, 2025
pulisher
Nov 04, 2025

Barclays Maintains Exact Sciences (EXAS) Overweight Recommendation - Nasdaq

Nov 04, 2025
pulisher
Nov 04, 2025

Key facts: Exact Sciences Q3 Revenue Hits $850.7M; Cancerguard Launched; Analysts Raise Price Targets - TradingView

Nov 04, 2025
pulisher
Nov 04, 2025

EXAS: TD Cowen Raises Price Target to $90 on Buy Rating | EXAS S - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences (EXAS) Receives Updated Analyst Rating from Baird - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

EXAS: Benchmark Raises Price Target to $75 in Latest Analyst Rev - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

EXAS: Guggenheim Raises Price Target to $75 While Maintaining Bu - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

Stifel raises Exact Sciences stock price target to $80 on strong Cologuard growth - Investing.com Canada

Nov 04, 2025
pulisher
Nov 04, 2025

EXAS: Barclays Raises Price Target to $77, Maintains Overweight Rating | EXAS Stock News - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results - Benzinga

Nov 04, 2025
pulisher
Nov 04, 2025

Madison-based Exact Sciences reports Q3 results topping analysts’ expectations - Wisconsin State Journal

Nov 04, 2025
pulisher
Nov 04, 2025

EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth - Yahoo! Finance Canada

Nov 04, 2025
pulisher
Nov 04, 2025

EXAS: Stifel Raises Target Price to $80, Maintains Buy Rating | - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

BTIG Raises Price Target for Exact Sciences (EXAS) to $85 | EXAS Stock News - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences stock price target raised to $85 from $75 at BTIG - Investing.com

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences to Participate in November Investor Conference - Bluefield Daily Telegraph

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences: Q3 Earnings Snapshot - theheraldreview.com

Nov 04, 2025
pulisher
Nov 04, 2025

How Intuitive Surgical Stock Gained 19.5% Last Month - AOL.com

Nov 04, 2025
pulisher
Nov 04, 2025

Canaccord Genuity raises Exact Sciences stock price target to $85 on strong growth - Investing.com

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences Corp (EXAS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 04, 2025
pulisher
Nov 04, 2025

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

Exact Sciences Corp (EXAS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 04, 2025
pulisher
Nov 03, 2025

Exact Sciences Reports Record Q3 Revenue and Raises Guidance - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

Transcript : Exact Sciences Corporation, Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Exact Sciences Q3 2025 slides: 20% revenue growth, guidance raised - Investing.com

Nov 03, 2025

Exact Sciences Corp (EXAS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Exact Sciences Corp (EXAS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Baranick Brian
EVP, GM, Precision Oncology
Nov 04 '25
Sale
70.08
2,858
200,289
22,368
diagnostics_research DGX
$179.50
price up icon 1.69%
diagnostics_research LH
$252.72
price up icon 2.47%
diagnostics_research WAT
$371.69
price up icon 0.14%
$199.57
price up icon 0.55%
diagnostics_research MTD
$1,439.35
price down icon 0.02%
diagnostics_research IQV
$210.46
price down icon 0.19%
大文字化:     |  ボリューム (24 時間):